This is a phase 3 randomised, double-blinded, placebo-controlled trial in adult subjects with moderate-to-severe AD. The trial will consist of a screening period of 2 to 6 weeks (Weeks -6/-2 to 0), an initial treatment period of 16 weeks (Weeks 0 to 16) and a maintenance treatment period of 36 weeks (Weeks 16 to 52).
Do you Qualify?
These questions require a yes answer to qualify.
Are you at least 18 years of age?
Have you been clinically diagnosed for at least 1 year?
Does your effected skin area cover at least 10% of your body?
These questions require a no answer to qualify.
Are you currently pregnant, plan to become pregnant or breastfeeding?
Have you ever had anaphylactic symptoms?
Currently suffering from any major illnesses that may require extended hospitalization?
In the past year have you suffered with any chronic drug or alcohol abuse?
If you think you may be eligible for this trial, please give us a call to schedule an appointment or click button below to email a request.